Literature DB >> 16873922

The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease.

Federica Mondolo1, Marjan Jahanshahi, Alessia Granà, Emanuele Biasutti, Emanuela Cacciatori, Paolo Di Benedetto.   

Abstract

We assessed the concurrent validity of the Hospital Anxiety and Depression Scale (HADS) and the Geriatric Depression Scale (GDS) against the Hamilton Rating Scale for Depression (Ham-D) in patients with Parkinson's disease (PD). Forty-six non-demented PD patients were assessed by a neurologist on the Ham-D. Patients also completed four mood rating scales: the HADS, the GDS, the VAS and the Face Scale. For the HADS and the GDS, Receiver Operating Characteristics (ROC) curves were obtained and the positive and negative predictive values (PPV, NPV) were calculated for different cut-off scores. Maximum discrimination between depressed and non-depressed PD patients was reached at a cut-off score of 10/11 for both the HADS and the GDS. At the same cut-off score of 10/11 for both the HADS and the GDS, the high sensitivity and NPV make these scales appropriate screening instruments for depression in PD. A high specificity and PPV, which is necessary for a diagnostic test, was reached at a cut-off score of 12/13 for the GDS and at a cut-off score of 11/12 for the HADS. The results indicate the validity of using the HADS and the GDS to screen for depressive symptoms and to diagnose depressive illness in PD.

Entities:  

Mesh:

Year:  2006        PMID: 16873922      PMCID: PMC5471536          DOI: 10.1155/2006/136945

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  19 in total

1.  Parkinson disease: Scales to detect depression in Parkinson disease.

Authors:  Anette Schrag; Albert F Leentjens
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

2.  Toward Understanding Ambulatory Activity Decline in Parkinson Disease.

Authors:  James T Cavanaugh; Terry D Ellis; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Leland E Dibble
Journal:  Phys Ther       Date:  2015-04-09

3.  Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Jojo Y Y Kwok; Jackie C Y Kwan; M Auyeung; Vincent C T Mok; Claire K Y Lau; K C Choi; Helen Y L Chan
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

4.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

5.  Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients.

Authors:  Marlies van Nimwegen; Arlène D Speelman; Katrijn Smulders; Sebastiaan Overeem; George F Borm; Frank J G Backx; Bastiaan R Bloem; Marten Munneke
Journal:  BMC Neurol       Date:  2010-08-19       Impact factor: 2.474

6.  Clinical correlates of depressive symptoms in familial Parkinson's disease.

Authors:  Nathan Pankratz; Karen S Marder; Cheryl A Halter; Alice Rudolph; Cliff W Shults; William C Nichols; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

7.  Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.

Authors:  Marina Picillo; Gabriella Santangelo; Marcello Moccia; Roberto Erro; Marianna Amboni; Elio Prestipino; Katia Longo; Carmine Vitale; Emanuele Spina; Giuseppe Orefice; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

Review 8.  Rating scales for anxiety/anxiety disorders.

Authors:  Richard Balon
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 9.  Depression and apathy in Parkinson's disease.

Authors:  Irene Hegeman Richard
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

Review 10.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.